LexDanaLexDanabeta
Inventor

David E. Gunn

Inventor
Hamden, CT, US

Overview

24→
Patents
1995–2013
Patent span
Human necessities
Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds44%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
A61KPreparations for medical, dental or toiletry purposes10%
C07CAcyclic or carbocyclic compounds4%
Y02ATechnologies for adaptation to climate change4%
PatentTitleYear
8,431,695'Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases'20138,163,932'Substituted indolealkanoic acids'20127,928,239'Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas'20117,659,269'Substituted indolealkanoic acids'20107,517,880'Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas'20097,371,763'Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas'20087,304,079'Substituted indolealkanoic acids'20077,109,196'1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders'20067,105,514'Substituted indolealkanoic acids'20066,900,205'1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders'20056,784,167'17-beta-hydroxysteroid dehydrogenase-II inhibitors'20046,730,794'Substituted indolealkanoic acids'20046,426,344'Aryl and heteroaryl substituted indolealkanoic acids'20026,344,476'Inhibition of p38 kinase activity by aryl ureas'20026,214,991'Substituted indolealkanoic acids'20015,948,793'3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release'19995,914,328'Heterocyclic ether compounds useful in controlling neurotransmitter release'19995,843,968'Symmetrical bis-heteroarylmethoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis'19985,795,900'Symmetrical bis-heteroaryl-methoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis'19985,783,586'Heteroarylmethoxyphenylthioalkyl carboxylates as inhibitors of leukotriene biosynthesis'19985,756,531'Iminoxy derivatives of indole and indene compounds as inhibitors of prostaglandin biosynthesis'19985,691,351'Bis-(Heteroarylmethoxyphenyl)cycloalkyl carboxylates as inhibitors of leukotriene biosynthesis'19975,668,150'Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis'19975,472,958'2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–1999Patents assigned to ABBOTT LAB (9)· patent assignee history
1995–1999Based in Waukegan, IL, US· patent location history
1997–2013Based in Hamden, CT, US· patent location history
2001–2010Patents assigned to INST PHARMACEUTICAL DISCOVERY (4)· patent assignee history
2004–2009Patents assigned to BAYER PHARMACEUTICALS CORP (5)· patent assignee history
2012–2013Patents assigned to GUNN DAVID (2)· patent assignee history
2013Patents assigned to ACHEBE FURAHI (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ABBOTT LAB91995–1999
BAYER PHARMACEUTICALS CORP52004–2009
INST PHARMACEUTICAL DISCOVERY42001–2010
GUNN DAVIDself22012–2013
ACHEBE FURAHI12013
Locations
LocationPatentsSpan
Hamden, CT, US201997–2013
Waukegan, Illinois, US41995–1999